Themis Medicare Limited
Themis Medicare Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: THEMISMED and BSE: 530199 (ISIN INE083B01024).
It has a market capitalisation of ₹926 crore, a last close of ₹100.53 on 2026-10-19, a one-year return of -19.7%.
Valuation: a price-to-earnings ratio of 23.16x, a price-to-book ratio of 2.32x, a dividend yield of 0.5%.
Profitability: return on equity of 0.3%, return on capital employed of -0.3%, an operating margin of -12.6%.
Growth: sales growth of -1.2% a year over three years, net profit growth of -72.8% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.25x, promoter holding of 67.1%.
| Metric | Value |
|---|---|
| Market capitalisation | 926 |
| Last close | ₹100.53 |
| P/E (TTM) | 23.16x |
| P/B | 2.32x |
| Dividend yield | 0.5% |
| ROE (FY) | 0.3% |
| ROCE (FY) | -0.3% |
| Operating margin (TTM) | -12.6% |
| Sales growth, 3-year CAGR | -1.2% |
| Profit growth, 3-year CAGR | -72.8% |
| Debt / equity | 0.25x |
| Promoter holding | 67.1% |
| 1-year return | -19.7% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means